Influence of mature mDC and CD163+ MΦ on the clinical outcome of cHL patients.
- Christiane Silke Tudor (669015)
- Heiko Bruns (469100)
- Christoph Daniel (282746)
- Luitpold Valentin Distel (669016)
- Arndt Hartmann (42756)
- Armin Gerbitz (174530)
- Maike Julia Buettner (669017)
Publication date
December 2014
DOIAbstract
<p>Kaplan-Meier-Analysis of disease-specific survival (DSS) of cHL patients with regard to the numbers of infiltrating CD83+ mature mDC (A) and CD163+ MΦ (B, C). (A) The mean and (B) the 50<sup>th</sup> percentile and (C) the 75<sup>th</sup> percentile were used as cut-off, to define the groups with high and low numbers of CD83+ cell/mm<sup>2</sup> and CD163+ cell/mm<sup>2</sup>.</p
Add to ORKG